CLVS

Clovis Oncology, Inc.
CLVS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

2 hedge funds and large institutions have $520K invested in Clovis Oncology, Inc. in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$510K

Top Sellers

1
-$479K
2
-$13K
3
-$12.7K
4
CASC
Coppell Advisory Solutions Corp
Texas
-$12.7K
5
STB
S&T Bank
Pennsylvania
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$518K
2
$2.18K
3
–
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–